MIV-701

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMIV-701
Drug Alias NameMIV-701
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin K inhibitors
TargetsCathepsin K
Therapy Area/IndicationsOsteoporosis, PostmenopausalOsteoporosisNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedivir AB
Active IndicationsN/A
Inactive IndicationsOsteoporosis, PostmenopausalOsteoporosisNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A